This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 1979.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1979
Title: Edward M Cohen: Innovator in Ophthalmic Medication
Introduction
Edward M Cohen is a notable inventor based in Beaumont, France. He has made significant contributions to the field of ophthalmic medication, particularly through his innovative patent. His work focuses on improving the delivery and effectiveness of medications for eye treatment.
Latest Patents
Cohen holds a patent for a solid state ophthalmic medication. This patent describes solid unit dosage medicaments that are suitable for use in both animals and humans. The medicaments are formulated with hydroxypropyl cellulose as the primary excipient. They are designed to be slowly and completely water-soluble when inserted into the cul-de-sac of the eye. This formulation allows for prolonged treatment of the eye while reducing the frequency of dosing.
Career Highlights
Cohen is associated with Merck & Co., Inc., a leading global healthcare company. His work at Merck has allowed him to focus on developing innovative solutions in the pharmaceutical industry. His contributions have been instrumental in advancing ophthalmic treatments.
Collaborations
Throughout his career, Cohen has collaborated with notable colleagues, including Gunvant N Mehta and Wayne M Grim. These collaborations have further enhanced the development of effective ophthalmic medications.
Conclusion
Edward M Cohen's innovative work in ophthalmic medication exemplifies the importance of research and development in healthcare. His patent for solid state ophthalmic medication represents a significant advancement in the treatment of eye conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile